Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in O (Q59315342)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in O	article

Statements

scholarly article

0 references

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in O (English)

0 references

phase II clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

16

object named as

Sergio Giralt

0 references

Richard A. Larson

12

object named as

Richard A Larson

0 references

Richard E Champlin

7

object named as

Richard E Champlin

0 references

Steven M Devine

1

object named as

Steven M Devine

0 references

Robert J Soiffer

11

object named as

Robert J Soiffer

0 references

20

object named as

Edwin P Alyea

0 references

Richard M Stone

5

object named as

Richard M Stone

0 references

author name string

Kouros Owzar

2

0 references

William Blum

3

0 references

Flora Mulkey

4

0 references

Jack W Hsu

6

0 references

Yi-Bin Chen

8

0 references

Ravi Vij

9

0 references

James Slack

10

0 references

Thomas C Shea

13

0 references

Vera Hars

14

0 references

Alexander B Sibley

15

0 references

Shelly Carter

17

0 references

Mary M Horowitz

18

0 references

Charles Linker

19

0 references

language of work or name

0 references

publication date

10 December 2015

0 references

Journal of Clinical Oncology

0 references

33

0 references

35

0 references

4167-75

0 references

A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age and acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose daunorubicin in older patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How I treat acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral-blood stem cells versus bone marrow from unrelated donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival for older patients with acute myeloid leukemia: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Older patients/older donors: choosing wisely

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors in Older Patients With Myeloid Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26527780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2015.62.7273

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q59315342&oldid=2265558968"